These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15286788)

  • 1. Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19.
    Seow HF; Bröer S; Bröer A; Bailey CG; Potter SJ; Cavanaugh JA; Rasko JE
    Nat Genet; 2004 Sep; 36(9):1003-7. PubMed ID: 15286788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder.
    Kleta R; Romeo E; Ristic Z; Ohura T; Stuart C; Arcos-Burgos M; Dave MH; Wagner CA; Camargo SR; Inoue S; Matsuura N; Helip-Wooley A; Bockenhauer D; Warth R; Bernardini I; Visser G; Eggermann T; Lee P; Chairoungdua A; Jutabha P; Babu E; Nilwarangkoon S; Anzai N; Kanai Y; Verrey F; Gahl WA; Koizumi A
    Nat Genet; 2004 Sep; 36(9):999-1002. PubMed ID: 15286787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral amino acid transport in epithelial cells and its malfunction in Hartnup disorder.
    Bröer S; Cavanaugh JA; Rasko JE
    Biochem Soc Trans; 2005 Feb; 33(Pt 1):233-6. PubMed ID: 15667315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutation in SLC6A19 causing late-onset seizures in Hartnup disorder.
    Cheon CK; Lee BH; Ko JM; Kim HJ; Yoo HW
    Pediatr Neurol; 2010 May; 42(5):369-71. PubMed ID: 20399395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for allelic heterogeneity in Hartnup disorder.
    Azmanov DN; Kowalczuk S; Rodgers H; Auray-Blais C; Giguère R; Rasko JE; Bröer S; Cavanaugh JA
    Hum Mutat; 2008 Oct; 29(10):1217-21. PubMed ID: 18484095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hartnup disorder: unraveling the mystery.
    Kraut JA; Sachs G
    Trends Pharmacol Sci; 2005 Feb; 26(2):53-5. PubMed ID: 15681018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel missense mutation in the SLC6A19 gene in a Chinese family with Hartnup disorder.
    Zheng Y; Zhou C; Huang Y; Bu D; Zhu X; Jiang W
    Int J Dermatol; 2009 Apr; 48(4):388-92. PubMed ID: 19335424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the neutral amino acid transporter B0AT1 (SLC6A19) in Hartnup disorder and protein nutrition.
    Bröer S
    IUBMB Life; 2009 Jun; 61(6):591-9. PubMed ID: 19472175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of mouse amino acid transport system B0, a neutral amino acid transporter related to Hartnup disorder.
    Bröer A; Klingel K; Kowalczuk S; Rasko JE; Cavanaugh J; Bröer S
    J Biol Chem; 2004 Jun; 279(23):24467-76. PubMed ID: 15044460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of the common Hartnup disease D173N allele in populations of European origin.
    Azmanov DN; Rodgers H; Auray-Blais C; Giguère R; Bailey C; Bröer S; Rasko JE; Cavanaugh JA
    Ann Hum Genet; 2007 Nov; 71(Pt 6):755-61. PubMed ID: 17555458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations.
    Camargo SM; Singer D; Makrides V; Huggel K; Pos KM; Wagner CA; Kuba K; Danilczyk U; Skovby F; Kleta R; Penninger JM; Verrey F
    Gastroenterology; 2009 Mar; 136(3):872-82. PubMed ID: 19185582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protein complex in the brush-border membrane explains a Hartnup disorder allele.
    Kowalczuk S; Bröer A; Tietze N; Vanslambrouck JM; Rasko JE; Bröer S
    FASEB J; 2008 Aug; 22(8):2880-7. PubMed ID: 18424768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hartnup disorder: Pathogenesis, pathophysiology, and therapy].
    Ohura T
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():541-4. PubMed ID: 16523951
    [No Abstract]   [Full Text] [Related]  

  • 14. Homozygosity mapping to chromosome 5p15 of a gene responsible for Hartnup disorder.
    Nozaki J; Dakeishi M; Ohura T; Inoue K; Manabe M; Wada Y; Koizumi A
    Biochem Biophys Res Commun; 2001 Jun; 284(2):255-60. PubMed ID: 11394870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of neutral aminoacidurias.
    Bröer A; Cavanaugh JA; Rasko JE; Bröer S
    Pflugers Arch; 2006 Jan; 451(4):511-7. PubMed ID: 16052352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis.
    Town M; Jean G; Cherqui S; Attard M; Forestier L; Whitmore SA; Callen DF; Gribouval O; Broyer M; Bates GP; van't Hoff W; Antignac C
    Nat Genet; 1998 Apr; 18(4):319-24. PubMed ID: 9537412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic analysis of SLC3A1 and SLC7A9 genes in Czech and Slovak cystinuric patients.
    Skopková Z; Hrabincová E; Stástná S; Kozák L; Adam T
    Ann Hum Genet; 2005 Sep; 69(Pt 5):501-7. PubMed ID: 16138908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19.
    Böhmer C; Sopjani M; Klaus F; Lindner R; Laufer J; Jeyaraj S; Lang F; Palmada M
    Cell Physiol Biochem; 2010; 25(6):723-32. PubMed ID: 20511718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hartnup disorder: polymorphisms identified in the neutral amino acid transporter SLC1A5.
    Potter SJ; Lu A; Wilcken B; Green K; Rasko JE
    J Inherit Metab Dis; 2002 Oct; 25(6):437-48. PubMed ID: 12555937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired nutrient signaling and body weight control in a Na+ neutral amino acid cotransporter (Slc6a19)-deficient mouse.
    Bröer A; Juelich T; Vanslambrouck JM; Tietze N; Solomon PS; Holst J; Bailey CG; Rasko JE; Bröer S
    J Biol Chem; 2011 Jul; 286(30):26638-51. PubMed ID: 21636576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.